Understanding Cancer & How Treatment Really Works

When did cancer actually start?

By the time a cancer is visible on a scan, it has usually been growing silently for years.

A tumor becomes detectable when it reaches about 1 billion cells (10⁹). To reach that number, cancer must divide again and again. It takes roughly 30 doublings — because 2³⁰ ≈ 1 billion.

So depending on how fast it grows: a cancer that doubles monthly may take years to appear; a cancer that doubles weekly may appear within months.

This is why two people can develop cancer at the same time, but one is diagnosed much later. Cancer doesn’t start when we detect it. It starts long before.

Why surgery alone is not always enough

Removing a visible tumor is important. But cancer is not just what we can see.

By the time a tumor forms, tiny cancer cells may already have spread — some may be circulating in blood, some may be hiding in distant organs. These microscopic cells cannot be detected on scans.

This is why additional treatment is often needed after surgery: chemotherapy, targeted therapy, hormonal therapy, immunotherapy. The goal is to treat disease we cannot see.

Why treatment happens in phases

Cancer treatment is rarely a single step. It usually happens in layers: diagnosis, local treatment (surgery / radiation), systemic treatment, follow-up monitoring.

Each phase targets a different part of the disease. Stopping early increases the risk that hidden cancer cells survive.

If the cancer responded, why continue treatment?

This is one of the most common questions. When scans improve, it means treatment is working. But response does not always mean cure.

Even when a tumor shrinks, some cancer cells may still remain. These cells can regrow if treatment stops early. Continuing treatment reduces the risk of relapse. This is why doctors often recommend completing full treatment plans even after early improvement.

Why treatment decisions are individual

Two patients with the same cancer may receive different treatments. This depends on: stage of disease, age, overall health, response to therapy, and risk of relapse.

Treatment is tailored, not standardized.

How we judge whether a cancer treatment truly works

When a new cancer treatment is recommended, a common question is: How do we know this drug actually helps? Treatment decisions in medical oncology are guided by clinical trial data. But the benefit of a treatment is not measured in just one way. Researchers use specific outcomes — called endpoints — to understand whether a therapy is making a meaningful difference.

Overall survival: the most meaningful outcome

The most important measure is overall survival. This simply asks: Do patients live longer after receiving this treatment? It is considered the gold standard because it directly reflects the outcome that matters most. If a treatment improves overall survival compared to standard care, it is strong evidence of real benefit. However, measuring this takes time. Patients often need to be followed for years before clear differences appear.

Progression-free survival: an earlier signal

Another commonly used measure is progression-free survival. This looks at: How long the cancer stays under control without growing or spreading. This can be measured sooner and helps us identify early signals that a treatment is working. But there is an important distinction: A treatment can delay progression without necessarily helping patients live longer. Both outcomes matter — but they are not the same.

Other ways we measure treatment benefit

Depending on the situation, we may also look at:

• Disease-free survival: How long patients remain cancer-free after treatment
• Response rates: How many patients experience tumor shrinkage
• Quality of life measures: Relief from symptoms like pain or breathlessness
• Biomarkers: Changes in levels like PSA or CA-125

Each of these tells us something different about how a treatment is helping.

Why this matters during treatment decisions

When we discuss treatment options, these distinctions help guide expectations. Some therapies improve survival; some delay progression; some improve symptoms; some do a combination of all three. Understanding this helps patients make more informed decisions. Medical oncology is not just about giving treatment. It is about choosing the right treatment based on meaningful evidence.

The goal of chemotherapy

Chemotherapy is given for different reasons: cure, control disease, prevent recurrence, or relieve symptoms. Each plan is tailored to the individual. Understanding the process helps reduce fear and helps patients stay consistent with treatment.

Should you switch doctors during cancer treatment?

For why continuity of care matters and what to bring when you do change doctors, see our page on understanding cancer and how treatment works.

When treatment doesn't go as expected, it is natural to wonder: "Should I try another doctor?" "Would someone else do something different?" This is a very human reaction. Cancer treatment is emotionally heavy, uncertain, and often unpredictable. When results are not what we hoped for, people start searching for answers — and sometimes, a new doctor feels like a fresh start. But there are a few important realities worth understanding.

Cancer is not one disease

Cancer is not a single condition. It is hundreds of different diseases. Even with all the treatments we now have — chemotherapy, surgery, radiation, targeted therapy, immunotherapy — some cancers respond well, and some do not. When treatment fails, it does not automatically mean the wrong doctor, the wrong drug, or a missed opportunity. Sometimes, it is simply the biology of the disease.

Why continuity of care matters

Over time, your oncologist learns things about you that never fully appear in reports: how you tolerate specific drugs, small dose adjustments that worked, side-effects you experienced, how your disease behaved over time, and your personal priorities and fears. This accumulated understanding becomes part of your treatment. It is not always visible in medical records, but it can be very important.

When switching doctors may NOT help

Changing doctors repeatedly just because the disease is not responding, treatment is difficult, side effects are stressful, or progress feels slow may not improve outcomes. Cancer care is rarely linear. Many patients require multiple lines of treatment, adjustments, and time. Switching frequently can disrupt treatment continuity, decision-making consistency, and long-term planning.

When a second opinion makes sense

Seeking a second opinion is completely reasonable and often helpful. Consider it when: diagnosis is unclear; a major treatment decision is being made; a rare cancer is involved; a transplant or complex therapy is being planned; you feel communication is poor; or you are not comfortable with the approach being taken. A good oncologist will not feel threatened by a second opinion.

When changing doctors is justified

Switching doctors may be appropriate if you feel unheard or dismissed, your concerns are not addressed, communication is unclear, or you have lost trust in the care being provided. Trust is essential in cancer care. Without it, treatment becomes much harder for both patient and doctor.

A balanced way to think about it

Second opinions are healthy. Doctor shopping out of fear or frustration is different. The goal is not to find someone who promises more. The goal is to find someone you trust to be honest — even when the news is difficult. Consistency, clarity, and communication often matter more than constantly changing directions.

Making the most of your oncology consultation

Cancer care is rarely a single visit. It is a process that involves multiple decisions, discussions, and long-term follow-up. A consultation works best when both the doctor and the patient come prepared. Small practical steps can make the visit more meaningful and efficient.

Bring your previous medical records

Carrying earlier reports, scans, prescriptions, and discharge summaries helps significantly. It allows us to avoid repeating unnecessary tests, understand how the illness has evolved, and make faster and more accurate decisions. Even reports from months or years ago can be clinically relevant.

Understand that delays can happen

Waiting is difficult, especially on emotionally heavy days. But oncology practice is unpredictable. Sometimes delays occur because a critically ill patient needs urgent attention, a family requires detailed counselling, or a treatment complication needs to be stabilised. These situations cannot be rushed, and they affect the schedule for the rest of the day.

Start each consultation with a clean slate

Many patients come after difficult experiences elsewhere. That is understandable. But beginning a new consultation without carrying earlier frustrations helps create a more focused and productive interaction. Each doctor may approach problems differently, and a fresh evaluation often leads to new perspectives.

Open communication makes care better

Questions are always welcome. It helps to discuss concerns about treatment, doubts about previous advice, fears about side effects, and expectations from therapy. Clear communication allows us to plan treatment more precisely.

Cancer care works best as a partnership

Oncology is not a one-time decision. It involves repeated visits, reassessment, and long-term follow-up. When there is preparation, trust, and mutual respect, the focus stays where it should be — on making the best possible treatment decisions.

Preparing for your first oncology appointment

The first visit to an oncologist often comes after a difficult diagnosis. Most patients arrive with a mix of anxiety, questions, and uncertainty. Knowing how to prepare can make the consultation more productive and less overwhelming.

Understand the treatment discussion

During the first few visits, we usually discuss the diagnosis in detail, the stage of the disease, treatment options, expected duration of therapy, and possible side effects. It helps to be ready with questions such as: How many treatment cycles are likely? Will treatment stop after a fixed plan, or continue based on response? What side effects should I expect? When should I seek urgent medical help? Clarity early on makes the journey easier.

Bring all previous reports

Carry biopsy reports, scan reports, blood tests, and discharge summaries. This helps avoid repeating tests and allows faster decision-making. Even older records can be useful.

Planning for IV access (if chemotherapy is advised)

If treatment involves intravenous chemotherapy, we will assess your veins to decide whether a regular IV line is sufficient or a chemoport may be needed for long-term treatment. A chemoport is often considered when treatment is expected to continue for many months, certain drugs can damage tissues if they leak outside veins, or repeated access may be difficult. This is a discussion that usually happens early in the treatment planning phase.

Understand where treatment may happen

Depending on the treatment plan, therapy may be given as day-care treatment lasting a few hours, short hospital admissions, or home infusion in selected situations. Knowing this in advance helps with planning work, travel, and family support.

Financial planning helps reduce stress

Cancer treatment can be expensive. It is useful to clarify early: insurance coverage, pre-approval requirements, estimated out-of-pocket costs, and whether consultations are needed before each cycle. If cost is a concern, generic drug options may sometimes be available. Planning this ahead prevents delays later.

Bring a support person

The first consultation often involves a lot of information. Having someone with you helps remember details, ask questions, and provide emotional support. Two people usually understand and retain information better than one.

Emotional preparation matters

The first oncology visit is not just medical. It can be emotionally overwhelming. What helps: taking notes during the consultation, asking questions without hesitation, taking time to process decisions, and leaning on family support. You don't have to understand everything in one visit. This is the beginning of a long, guided process.

Does cancer run in families? Understanding genetic risk

One of the most common questions I hear is from family members after a consultation: "Since someone in our family has cancer, what is my risk?" It is an important question. And the first thing to understand is this: Having a family member with cancer does not automatically mean you will develop cancer too. In fact, only about 5–10% of all cancers are truly hereditary.

What actually affects your cancer risk?

When we assess family history, we look at three main factors: How closely related you are — risk is more relevant when cancer occurs in parents, siblings, or children. The age at diagnosis — cancers that occur at a younger-than-expected age may raise suspicion of genetic risk. The number of affected relatives — multiple family members with similar cancers can sometimes indicate an inherited pattern. These details help us decide whether further evaluation is needed.

Why family history is often unclear

In the past, cancer was not always discussed openly within families. Information was often incomplete or vague: the exact type of cancer was not known, the organ involved was sometimes unclear, and genetic testing was not available. This makes it harder to interpret risk based only on history. Fortunately, modern genetic testing has changed how we approach this.

How genetic testing helps

Today, if we identify a genetic mutation in a patient, we can test family members and guide preventive care more precisely. For example: if a young patient with breast cancer is found to have a BRCA mutation, relatives can be tested and monitored more closely. This allows for earlier detection, preventive strategies, and more informed decisions. Even when family history is incomplete, testing can provide clarity.

Common hereditary cancer syndromes

There are several well-recognised genetic conditions linked to increased cancer risk. Some important ones include: BRCA mutations — associated mainly with breast and ovarian cancers. Lynch syndrome — linked to colorectal and certain other cancers. Li-Fraumeni syndrome — associated with cancers in multiple organs, often at younger ages. Familial adenomatous polyposis (FAP) — causes large numbers of colon polyps and increases colorectal cancer risk. Von Hippel–Lindau syndrome — linked to tumours in multiple organ systems. These are uncommon overall, but important to recognise when patterns suggest risk.

Warning signs in a family history

Certain patterns make us think more seriously about genetic risk: cancer occurring earlier than usual; multiple relatives with the same type of cancer; one person developing multiple different cancers; similar cancer patterns across generations. These do not confirm a hereditary condition, but they are signals that further evaluation may be needed.

Hereditary risk vs familial association

It is important to distinguish between two concepts. Hereditary risk involves specific gene mutations that can be identified through testing. These cancers often occur at younger ages and may affect multiple family members. Familial association is when several family members develop cancer without a known genetic mutation. This may be related to shared lifestyle, environment, or chance. These cancers usually occur at the typical age range. Understanding this difference helps guide decisions about screening and testing.

Why knowing your risk matters

Some people worry that knowing about genetic risk will only create anxiety. But in many cases, it allows us to take practical steps, such as: starting screening earlier, screening more frequently, using preventive medications in selected situations, and planning long-term monitoring. Risk awareness can lead to earlier detection and better outcomes.

Why I tell my patients to ignore most cancer advice

One of the first things that happens after a cancer diagnosis is not a test, not a scan, and not a treatment. It is advice. Advice comes from everywhere: family, friends, neighbours, social media, people who "know someone who had cancer." "Eat this." "Don't eat that." "Try this treatment." "Go to this hospital." Almost everyone means well. But most of this advice does more harm than good.

Cancer is not a one-size-fits-all disease

Even if two people are told they have the same cancer — for example, Stage 2 breast cancer or Stage 4 lung cancer — the disease can behave very differently in each person. Treatment decisions depend on exact subtype, biology of the tumor, genetic markers, stage and spread, age and general health, and response to previous treatments. What worked for someone else may not work for you. And what failed for someone else does not mean it will fail for you.

How outside advice creates confusion

I often see patients struggle because of things they've heard from others: refusing treatment because a relative had a bad outcome; chasing miracle diets or supplements; losing hope because someone they knew did not survive; feeling pressured to try unproven therapies. These reactions are understandable — but they can delay or disrupt proper treatment.

Stories can inspire — but they should not guide treatment

It is perfectly fine to draw courage from someone who has completed treatment and is doing well. But their journey is not a medical roadmap for yours. The opposite is also true. Just because someone you know had a poor outcome does not mean your story will follow the same path.

So who should you listen to?

Your oncologist and your treatment team. They are the only people who know your exact diagnosis, understand your reports and scans, track how your body responds to treatment, and base decisions on scientific evidence. If you are unsure, the best thing you can do is ask questions: What are my treatment options? What is the goal of this treatment? What side effects should I expect? What happens if this does not work? Clarity reduces fear. And it protects you from misinformation.

A balanced perspective

Support from family and friends is important. Encouragement matters. But when it comes to treatment decisions, too many voices can create confusion. Use stories for strength. Use your doctor for direction.

Alternative Therapies in Cancer: What Really Helps — and What Can Harm?

Many patients and families ask about alternative therapies after a cancer diagnosis. It is a natural reaction. When faced with something overwhelming, people want to explore every possible option. But this is also an area where clarity matters the most.

First, the most important principle

Evidence-based medical treatment should remain the foundation of cancer care. Some complementary practices can improve quality of life and help manage symptoms. But when alternative treatments replace proven therapy, the consequences can be devastating. Over the years, I have seen young patients with highly treatable cancers — conditions where the chances of cure are excellent — choose alternative treatments first. When they return months later, the disease is often more advanced and harder to control. These are the most difficult moments in oncology, because the opportunity for cure may have already been lost.

What can actually help as supportive care

Some approaches can safely complement treatment and improve overall wellbeing: Yoga and gentle physical activity — helps reduce fatigue, improve flexibility, and lower stress. Meditation and mindfulness — can ease anxiety and improve sleep. Acupuncture (when performed by trained professionals) — may help with pain and certain treatment-related symptoms. These do not treat cancer itself, but they can help patients cope better during therapy.

What to be cautious about

Some commonly promoted options may interfere with treatment or delay care: Herbal supplements — many interact with chemotherapy, targeted therapy, or immunotherapy. Extreme diets — can worsen weight loss, weakness, and recovery. "Miracle cures" promoted online — often unsupported by scientific evidence. Patients sometimes spend large amounts of money on these approaches without benefit, and in some cases, they can cause harm.

The safest approach

If you are considering any alternative or complementary therapy: discuss it openly with your oncologist; make sure it does not interfere with your treatment; use it only as a supportive measure, not a replacement. Wanting to try everything possible is completely understandable. But the strongest chance of controlling or curing cancer still comes from treatments that have been scientifically tested and proven to work. Complementary therapies can support recovery. They should never replace the treatment that is meant to save your life.

Financial planning after a cancer diagnosis — why it matters

A cancer diagnosis changes many things — physically, emotionally, and financially. One topic that many families avoid discussing early is financial planning. But addressing it sooner can reduce stress, prevent confusion, and protect loved ones. This is not about expecting the worst. It is about staying prepared and organized during an uncertain time. Cancer treatment can affect ability to work, household income, ongoing expenses, insurance coverage, and long-term family security. Taking a few practical steps early can make a significant difference.

1) Keep important documents accessible

Make sure your family knows where to find bank account details, insurance documents, identification records, and hospital and medical files. This avoids panic and delays if urgent decisions need to be made. You do not need to share everything with everyone — just ensure one trusted person knows where essential information is stored.

2) Review your insurance coverage

Many patients are unsure about what their policy actually covers. Take time to check coverage limits, treatments included, renewal conditions, and beneficiary details. This helps avoid unexpected financial surprises during treatment.

3) Organize property and asset information

Maintain a simple record of houses and property documents, vehicles, investments, and valuable assets. Ensure these documents are stored safely and that a family member knows where they are.

4) List loans, EMIs, and financial commitments

Cancer treatment often overlaps with existing financial responsibilities. It helps to maintain clarity on home loans, personal loans, EMIs, and money owed to or by others. This prevents confusion and allows better planning.

5) Review legal planning

This is a sensitive topic, but an important one. Consider updating your will, assigning a trusted power of attorney (if needed), and ensuring documents are legally valid. This is not about pessimism. It is about protecting your family and reducing future complications.

6) Planning for business continuity (if applicable)

If you run a business or manage key responsibilities: document important processes, identify someone who can step in temporarily, and ensure essential contacts and accounts are accessible. Even short periods of illness can disrupt operations, so basic planning helps maintain stability.

A simple principle

Start early, while you are well enough to think clearly and make decisions comfortably. Even organizing one area at a time is helpful. This is not just financial planning. It is peace of mind for you and your family.

Understanding the final phase of advanced cancer

One of the most difficult questions families ask is: "How is this going to end?" "Will there be pain?" "Will it be sudden?" "How much time do we have?" These questions come from a place of love, fear, and the need to prepare. And the honest answer is: There is no single pattern. Every patient's journey is different.

Why it is hard to predict

As oncologists, we can often estimate how a disease behaves over time. But predicting exactly how and when life will end in an individual patient is extremely difficult. The course can vary widely depending on type of cancer, response to treatment, complications, and overall health.

Some patients decline suddenly

In certain situations, especially with blood cancers, decline can sometimes be rapid. This may happen due to severe infections when immunity is very low, bleeding complications, or sudden organ failure. These events can occur unexpectedly, even in patients who were relatively stable before.

For many patients, the course is gradual

In most advanced cancers, the decline is more prolonged. This may involve multiple relapses over time, disease becoming resistant to treatment, and fewer treatment options remaining. Gradually, the body becomes weaker and less able to tolerate further therapy. This phase may unfold over months rather than days.

What families often worry about most

The most common fears are severe pain, breathlessness, and suffering. Modern palliative care focuses heavily on comfort. Today, we have effective ways to manage pain, anxiety, breathlessness, and restlessness. The goal shifts from cure to comfort and dignity.

The role of supportive care

When cancer reaches a stage where treatment is no longer helping, the focus changes. Supportive and palliative care teams help with symptom control, emotional support, helping families prepare, and maintaining quality of life. This phase is about care, not abandonment.

What matters most in the final phase

For many families, the priorities become comfort, familiar surroundings, time together, and dignity. Every family and every patient approaches this phase differently. There is no single "right" way.

A difficult but important conversation

Talking about end-of-life does not take away hope. In fact, it often helps families prepare emotionally, make meaningful decisions, and focus on what truly matters. And in oncology, our responsibility continues even when treatment options end. Care does not stop. It simply changes direction.

Why follow-ups are necessary

Cancer care doesn’t end after treatment finishes. Follow-ups help to: detect relapse early, monitor long-term side effects, and ensure recovery is stable.

Many cancers are most likely to return in the first few years. Regular monitoring improves the chance of catching problems early.

Switching doctors during cancer care

Patients sometimes move between hospitals or cities during treatment. While this can happen, continuity is important because: treatment plans are long and structured, dose timing matters, and previous response guides future decisions.

When transitions happen, complete medical records and treatment summaries are essential.

The Indian reality: risk factors around us

Cancer risk is influenced by daily exposures over years. Common contributors include: tobacco use, pollution, processed foods, infections, and lifestyle patterns.

Awareness helps people make informed choices, but it’s important to understand: cancer is rarely caused by one single factor. It is usually the result of multiple exposures over time.